Scribe Therapeutics Inc (SCTX)

Scribe Therapeutics witnessed significant insider buying activity over the past ninety days, totaling over $71 million across nine transactions. Six distinct insiders, including institutional entities and executives, acquired shares following a strong performance in the latest results financiers. The stock price surged 96.5% during this period, reflecting heightened market interest.
Ticker: SCTX Exchange: NMS


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Scribe Therapeutics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Aghazadeh Behzad Non-Executive Director Large shareholder
Transaction date
Purchase
Price
160.04
Quantity 53,161 -26.6%
Value US$101,212
AH Bio Fund II, L.P. Large shareholder
Transaction date
Purchase
Price
157.34
Quantity 32,646 -31.0%
Value US$3,061,475
1.6
GORDON CARL L Non-Executive Director
Transaction date
Purchase
Price
463.36
Quantity 83,028 +28.2%
Value US$1,753,799
2.6
ORBIMED ADVISORS LLC Non-Executive Director
Transaction date
Purchase
Price
15.00
Quantity 1,000,000 +286.7%
Value US$15,000,000
Aghazadeh Behzad Non-Executive Director Large shareholder
Transaction date
Purchase
Price
22.31
Quantity 50,000 +1.6%
Value US$1,115,500
Aghazadeh Behzad Non-Executive Director Large shareholder
Transaction date
Purchase
Price
15.00
Quantity 2,333,333 +334.5%
Value US$34,999,995
1.5
Lucas Svetlana Chief Business Officer Officer
Transaction date
Purchase
Price
15.00
Quantity 3,000 +inf%
Value US$45,000
Parrot David Chief Financial Officer Officer
Transaction date
Purchase
Price
15.00
Quantity 1,333 +inf%
Value US$19,995
Parrot David Chief Financial Officer Officer
Transaction date
Purchase
Price
15.00
Quantity 1,333 +inf%
Value US$19,995
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2026-07-28 2026-07-28 B Purchase Non-Executive Director Large shareholder
53,161 -26.6%
160.04
US$101,212
53,161 -26.6% 160.04 US$101,212
2026-07-29 2026-07-27 B Purchase Large shareholder
32,646 -31.0%
157.34
US$3,061,475
32,646 -31.0% 157.34 US$3,061,475
2026-07-29 2026-07-27 B Purchase Non-Executive Director
83,028 +28.2%
463.36
US$1,753,799
83,028 +28.2% 463.36 US$1,753,799
2026-07-29 2026-07-27 B Purchase Non-Executive Director
1,000,000 +286.7%
15.00
US$15,000,000
1,000,000 +286.7% 15.00 US$15,000,000
2026-07-28 2026-07-24 B Purchase Non-Executive Director Large shareholder
50,000 +1.6%
22.31
US$1,115,500
50,000 +1.6% 22.31 US$1,115,500
2026-07-28 2026-07-24 B Purchase Non-Executive Director Large shareholder
2,333,333 +334.5%
15.00
US$34,999,995
2,333,333 +334.5% 15.00 US$34,999,995
2026-07-27 2026-07-23 B Purchase

Chief Business Officer

Officer
3,000 +inf%
15.00
US$45,000
3,000 +inf% 15.00 US$45,000
2026-07-27 2026-07-23 B Purchase

Chief Financial Officer

Officer
1,333 +inf%
15.00
US$19,995
1,333 +inf% 15.00 US$19,995
2026-07-27 2026-07-23 B Purchase

Chief Financial Officer

Officer
1,333 +inf%
15.00
US$19,995
1,333 +inf% 15.00 US$19,995